{"id":"https://openalex.org/W2072055545","doi":"https://doi.org/10.1111/j.1742-7843.2012.00908.x","title":"Rifampicin has a Profound Effect on the Pharmacokinetics of Oral S\u2010Ketamine and Less on Intravenous S\u2010Ketamine","display_name":"Rifampicin has a Profound Effect on the Pharmacokinetics of Oral S\u2010Ketamine and Less on Intravenous S\u2010Ketamine","alternate_titles":[],"publication_year":2012,"publication_date":"2012-06-27","ids":{"openalex":"https://openalex.org/W2072055545","doi":"https://doi.org/10.1111/j.1742-7843.2012.00908.x","mag":"2072055545","pmid":"https://pubmed.ncbi.nlm.nih.gov/22676424"},"language":"en","primary_location":{"id":"doi:10.1111/j.1742-7843.2012.00908.x","doi":"https://doi.org/10.1111/j.1742-7843.2012.00908.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1742-7843.2012.00908.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-7843.2012.00908.x","source":{"id":"https://openalex.org/S44074210","display_name":"Basic & Clinical Pharmacology & Toxicology","issn_l":"1742-7835","issn":["1742-7835","1742-7843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Basic &amp; Clinical Pharmacology &amp; Toxicology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2072055545"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-7843.2012.00908.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044955935","display_name":"Marko A. Peltoniemi","orcid":"https://orcid.org/0000-0003-1149-6825","observed_orcids":["https://orcid.org/0000-0003-1149-6825"]},"institutions":[{"id":"https://openalex.org/I155660961","display_name":"University of Turku","ror":"https://ror.org/05vghhr25","country_code":"FI","type":"education","lineage":["https://openalex.org/I155660961"]},{"id":"https://openalex.org/I2801970007","display_name":"Turku University Hospital","ror":"https://ror.org/05dbzj528","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2801970007","https://openalex.org/I4210127022"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marko A. Peltoniemi","raw_affiliation_strings":["Department of Anesthesiology, Intensive Care, Emergency Care, and Pain Medicine, University of Turku, and Turku University Hospital, Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Anesthesiology, Intensive Care, Emergency Care, and Pain Medicine, University of Turku, and Turku University Hospital, Turku, Finland","institution_ids":["https://openalex.org/I155660961","https://openalex.org/I2801970007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103241976","display_name":"Teijo I. Saari","orcid":"https://orcid.org/0000-0003-1225-4561","observed_orcids":["https://orcid.org/0000-0003-1225-4561"]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Teijo I. Saari","raw_affiliation_strings":["Department of Anesthesiology, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Anesthesiology, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083552727","display_name":"Nora\u00a0M. Hagelberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I155660961","display_name":"University of Turku","ror":"https://ror.org/05vghhr25","country_code":"FI","type":"education","lineage":["https://openalex.org/I155660961"]},{"id":"https://openalex.org/I2801970007","display_name":"Turku University Hospital","ror":"https://ror.org/05dbzj528","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2801970007","https://openalex.org/I4210127022"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nora M. Hagelberg","raw_affiliation_strings":["Department of Anesthesiology, Intensive Care, Emergency Care, and Pain Medicine, University of Turku, and Turku University Hospital, Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Anesthesiology, Intensive Care, Emergency Care, and Pain Medicine, University of Turku, and Turku University Hospital, Turku, Finland","institution_ids":["https://openalex.org/I155660961","https://openalex.org/I2801970007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105125841","display_name":"Kari Laine","orcid":"https://orcid.org/0009-0003-4124-7333","observed_orcids":["https://orcid.org/0009-0003-4124-7333"]},"institutions":[{"id":"https://openalex.org/I155660961","display_name":"University of Turku","ror":"https://ror.org/05vghhr25","country_code":"FI","type":"education","lineage":["https://openalex.org/I155660961"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kari Laine","raw_affiliation_strings":["Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, Finland","institution_ids":["https://openalex.org/I155660961"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056302141","display_name":"Kaisa J. Kurkinen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kaisa J. Kurkinen","raw_affiliation_strings":["Department of Clinical Pharmacology, University of Helsinki and HUSLAB, Helsinki University Central Hospital, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University of Helsinki and HUSLAB, Helsinki University Central Hospital, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089475081","display_name":"Pertti J. Neuvonen","orcid":"https://orcid.org/0000-0003-3631-9411","observed_orcids":["https://orcid.org/0000-0003-3631-9411"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pertti J. Neuvonen","raw_affiliation_strings":["Department of Clinical Pharmacology, University of Helsinki and HUSLAB, Helsinki University Central Hospital, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University of Helsinki and HUSLAB, Helsinki University Central Hospital, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I2800394112"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091721438","display_name":"Klaus Tapio Olkkola","orcid":"https://orcid.org/0000-0001-7872-8665","observed_orcids":["https://orcid.org/0000-0001-7872-8665"]},"institutions":[{"id":"https://openalex.org/I155660961","display_name":"University of Turku","ror":"https://ror.org/05vghhr25","country_code":"FI","type":"education","lineage":["https://openalex.org/I155660961"]},{"id":"https://openalex.org/I2801970007","display_name":"Turku University Hospital","ror":"https://ror.org/05dbzj528","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2801970007","https://openalex.org/I4210127022"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Klaus T. Olkkola","raw_affiliation_strings":["Department of Anesthesiology, Intensive Care, Emergency Care, and Pain Medicine, University of Turku, and Turku University Hospital, Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Anesthesiology, Intensive Care, Emergency Care, and Pain Medicine, University of Turku, and Turku University Hospital, Turku, Finland","institution_ids":["https://openalex.org/I155660961","https://openalex.org/I2801970007"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5103241976"],"corresponding_institution_ids":["https://openalex.org/I181369854"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":1.4548,"has_fulltext":true,"cited_by_count":59,"citation_normalized_percentile":{"value":0.75600043,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"111","issue":"5","first_page":"325","last_page":"332"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10436","display_name":"Anesthesia and Sedative Agents","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":0.9750000238418579},{"id":"https://openalex.org/keywords/esketamine","display_name":"esketamine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9229999780654907},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.875},{"id":"https://openalex.org/keywords/cytochrome-p450-induction","display_name":"cytochrome P450 induction","score":0.8640000224113464},{"id":"https://openalex.org/keywords/first-pass-metabolism","display_name":"first-pass metabolism","score":0.8769999742507935},{"id":"https://openalex.org/keywords/norketamine","display_name":"norketamine","score":0.9620000123977661},{"id":"https://openalex.org/keywords/oral-versus-intravenous-administration","display_name":"oral versus intravenous administration","score":0.7239999771118164},{"id":"https://openalex.org/keywords/pain-relief","display_name":"analgesia","score":0.6930000185966492},{"id":"https://openalex.org/keywords/pain-management","display_name":"pain management","score":0.4480000138282776}],"concepts":[{"id":"https://openalex.org/C2780795376","wikidata":"https://www.wikidata.org/wiki/Q243547","display_name":"Ketamine","level":2,"score":0.9392353296279907},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7809176445007324},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6611998677253723},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.6500104665756226},{"id":"https://openalex.org/C2778607973","wikidata":"https://www.wikidata.org/wiki/Q422652","display_name":"Rifampicin","level":3,"score":0.5998333692550659},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5185595154762268},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.4874291718006134},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.44222503900527954},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.07270553708076477},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000700","descriptor_name":"Analgesics","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000700","descriptor_name":"Analgesics","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000700","descriptor_name":"Analgesics","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001711","descriptor_name":"Biotransformation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004790","descriptor_name":"Enzyme Induction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011597","descriptor_name":"Psychomotor Performance","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012894","descriptor_name":"Sleep Stages","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1742-7843.2012.00908.x","doi":"https://doi.org/10.1111/j.1742-7843.2012.00908.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1742-7843.2012.00908.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-7843.2012.00908.x","source":{"id":"https://openalex.org/S44074210","display_name":"Basic & Clinical Pharmacology & Toxicology","issn_l":"1742-7835","issn":["1742-7835","1742-7843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Basic &amp; Clinical Pharmacology &amp; Toxicology","raw_type":"journal-article"},{"id":"pmid:22676424","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22676424","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Basic & clinical pharmacology & toxicology","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.1111/j.1742-7843.2012.00908.x","doi":"https://doi.org/10.1111/j.1742-7843.2012.00908.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1742-7843.2012.00908.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-7843.2012.00908.x","source":{"id":"https://openalex.org/S44074210","display_name":"Basic & Clinical Pharmacology & Toxicology","issn_l":"1742-7835","issn":["1742-7835","1742-7843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Basic &amp; Clinical Pharmacology &amp; Toxicology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2072055545.pdf","grobid_xml":"https://content.openalex.org/works/W2072055545.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W1584462211","https://openalex.org/W1607364964","https://openalex.org/W1964678251","https://openalex.org/W1966438037","https://openalex.org/W1967128261","https://openalex.org/W1969384722","https://openalex.org/W1972930816","https://openalex.org/W1978116407","https://openalex.org/W1990792515","https://openalex.org/W1994720749","https://openalex.org/W1998736820","https://openalex.org/W1999363883","https://openalex.org/W2001094052","https://openalex.org/W2011199593","https://openalex.org/W2013294274","https://openalex.org/W2022859618","https://openalex.org/W2022879463","https://openalex.org/W2030021013","https://openalex.org/W2043304730","https://openalex.org/W2061022065","https://openalex.org/W2069390464","https://openalex.org/W2074581066","https://openalex.org/W2094496261","https://openalex.org/W2096266931","https://openalex.org/W2120101425","https://openalex.org/W2128902684","https://openalex.org/W2135645785","https://openalex.org/W2151158180","https://openalex.org/W2155668422","https://openalex.org/W2164402249"],"related_works":["https://openalex.org/W2022879463","https://openalex.org/W2279621295","https://openalex.org/W2135645785","https://openalex.org/W2046692633","https://openalex.org/W1997211783","https://openalex.org/W2010077750","https://openalex.org/W2074581066","https://openalex.org/W1584462211","https://openalex.org/W4386923294","https://openalex.org/W2050109686"],"abstract_inverted_index":{"Low-dose":[0],"ketamine":[1,103,130,190,223],"is":[2,20],"currently":[3],"used":[4],"in":[5,50,58,70,85,96],"several":[6],"acute":[7],"and":[8,19,40,47,92,104,112,114,140,148,178,224],"chronic":[9],"pain":[10],"conditions":[11],"as":[12],"an":[13],"analgesic.":[14],"Ketamine":[15],"undergoes":[16],"extensive":[17],"metabolism":[18],"thus":[21],"susceptible":[22],"to":[23,109,118,134,189],"drug-drug":[24],"interactions.":[25],"We":[26],"examined":[27],"the":[28,43,86,90,97,124,128,157,173,183,203,211,219],"effect":[29],"rifampicin,":[30],"a":[31,71],"well-known":[32],"inducer":[33],"of":[34,45,89,102,138,161,176,185,214,222,229],"many":[35],"cytochrome":[36],"P450":[37],"(CYP)":[38],"enzymes":[39],"transporters,":[41],"on":[42],"pharmacokinetics":[44],"intravenous":[46,139,177,194],"oral":[48,141,162,179,212,227],"S-ketamine":[49,79,142,163,195],"healthy":[51,54],"volunteers.":[52],"Eleven":[53],"volunteers":[55],"were":[56,106],"administered":[57,81],"randomized":[59],"order":[60],"600":[61],"mg":[62],"rifampicin":[63],"or":[64],"placebo":[65],"orally":[66,93],"for":[67],"6":[68],"days":[69],"four-session":[72],"paired":[73],"cross-over":[74],"study.":[75],"On":[76],"day":[77],"6,":[78],"was":[80],"intravenously":[82],"(0.1":[83],"mg/kg)":[84,95],"first":[87],"part":[88],"study":[91],"(0.3":[94],"second":[98],"part.":[99],"Plasma":[100],"concentrations":[101,221],"norketamine":[105,186,225],"measured":[107],"up":[108,117],"24":[110],"hr":[111],"behavioural":[113],"analgesic":[115],"effects":[116],"12":[119],"hr.":[120],"Rifampicin":[121,154,181,216],"treatment":[122],"decreased":[123,155,182],"mean":[125],"area":[126],"under":[127],"plasma":[129,159,220],"concentration-time":[131],"curve":[132],"extrapolated":[133],"infinity":[135],"(AUC":[136],"(0-\u221e))":[137],"by":[143,164,196,205,231],"14%":[144],"(p":[145,150,166,198,207],"=":[146],"0.005)":[147],"86%":[149],"<":[151,167,199,208],"0.001),":[152,168],"respectively.":[153],"greatly":[156],"peak":[158],"concentration":[160],"81%":[165],"but":[169,201],"shortened":[170],"only":[171],"moderately":[172],"elimination":[174],"half-life":[175],"S-ketamine.":[180,215],"ratio":[184,204],"AUC":[187,191],"(0-\u221e)":[188,192],"after":[193,210,226],"66%,":[197],"0.001)":[200,209],"increased":[202],"147%":[206],"administration":[213,228],"profoundly":[217],"reduces":[218],"S-ketamine,":[230],"inducing":[232],"mainly":[233],"its":[234],"first-pass":[235],"metabolism.":[236]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2072055545","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
